Zacks Investment Research on MSNOpinion

Best strong buy momentum stocks to buy in February

The stock market jumped again on Tuesday as Wall Street begins arguably the most important week of the fourth quarter ...
QQEW has recently changed its underlying index to the Nasdaq-100 Select Equal Weight™ Index. Click here to read why QQEW ETF is a Hold.
However, since the stock remains significantly below its 50-day and 200-day moving averages, one must question whether this ...
MSCI offered some relief to Strategy investors on Tuesday, as the cryptocurrency holding company will get to stay in various indexes — for now. On paper, Strategy MSTR is a software business, even ...
Investing in uncertain times can call for different strategies than what have worked in the past. The AI trade and specific growth stocks continue to outperform, driving the market higher. However, if ...
Seventy-eight percent of the stock screens AAII tracks posted gains during 2025, with an average gain of 14.7%. What drove markets and sector leadership in 2025 How AAII’s quantitative stock screens ...
Forbes contributors publish independent expert analyses and insights. I consult on marketing strategy, content creation, and messaging. The market is pricing Strategy (NASDAQ: MSTR), formerly ...
The company's shares closed at a 15-month low, while the value of its bitcoin reserves declined to a more than seven-month low Strategy's stock fell to a 15-month low amid a decline in bitcoin prices ...
Shares of bitcoin-linked company Strategy has fallen over 45% in the past year, underperforming the world's biggest cryptocurrency. Michael Saylor, Strategy's cofounder and executive chairman, said ...
Strategy just raised $748 million to lift cash reserves to $2.19 billion and held its bitcoin balance steady at 671,268 BTC. Billionaire Bitcoin advocate Michael Saylor’s company, Strategy Inc., ...
Breast cancer is a heterogeneous disease characterized by the uncontrolled growth of malignant cells in breast tissue, arising from a complex interplay of genetic, hormonal, environmental, and ...
MSCI is consulting on excluding Strategy and similar firms from its indexes by February 2026. JPMorgan estimates exclusion could trigger $8.8B in outflows. Strategy stock has declined 39% year-to-date ...